A Study to Evaluate the Safety, Tolerability and Immunogenicity of Tau Targeted Vaccines in Participants With Early Alzheimer's Disease

Clinical trial NCT04445831 · COMPLETED

Trial details

NCT number: NCT04445831
Sponsor: AC Immune SA
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Alzheimer's Disease Cognitive Impairment Tauopathies Mild Cognitive Impairment Dementia Brain Diseases Central Nervous System Diseases

Start date: 2019-07-31
Primary completion: 2023-09-05
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.